Increase of B-50/GAP-43 immunoreactivity in uninjured muscle nerves of mdx mice

被引:15
|
作者
Verze, L
Buffo, A
Rossi, F
Oestreicher, AB
Gispen, WH
Strata, P
机构
[1] UNIV TURIN,DEPT HUMAN ANAT & PHYSIOL,I-10125 TURIN,ITALY
[2] UNIV UTRECHT,RUDOLF MAGNUS INST NEUROSCI,3534 CG UTRECHT,NETHERLANDS
关键词
sprouting; motoneuron; axonal remodelling; dystrophin; Duchenne muscular dystrophy;
D O I
10.1016/S0306-4522(96)83017-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Lack of dystrophin in Mdx mice leads to muscle fibre degeneration followed by the formation of new myofibres. This degeneration-regeneration event occurs in clusters. It is accompanied by inflammation and remodelling of the intramuscular terminal nerve fibres. Since the growth-associated protein B-50/GAP-43 has been shown to be involved in axonal outgrowth and synaptic remodelling following neuronal injury, we have investigated the presence of B-50 in gastrocnemius and quadriceps muscles of mdx mice. Using immunocytochemistry we demonstrate increased presence of B-50 in terminal nerve branches at motor endplates of mdx mice, particularly in the clusters of de- and regenerating myofibres. In comparison, the control mice displayed no B-50 immunoreactivity in nerve fibres contacting motor endplates. Our findings indicate that during axonal remodelling and collateral sprouting the B-50 level in the terminal axon arbours is increased although there is no direct injury to the motoneurons. We suggest that the degenerating target and/or the inflammatory reaction induces the increased B-50 level in the motoaxons. The increased B-50 may be important for sprouting of the nerve fibres and re-establishment of synaptic contacts, and in addition, for maturation and survival of the newly formed myofibres.
引用
收藏
页码:807 / 815
页数:9
相关论文
共 50 条
  • [31] The expression of B-50/GAP-43 and GFAP after bilateral olfactory bulbectomy in rats
    Cizkova, D
    Racekova, E
    Vanicky, I
    PHYSIOLOGICAL RESEARCH, 1997, 46 (06) : 487 - 495
  • [32] AXONAL-TRANSPORT AND LOCALIZATION OF B-50/GAP-43-LIKE IMMUNOREACTIVITY IN REGENERATING SCIATIC AND FACIAL NERVES OF THE RAT
    TETZLAFF, W
    ZWIERS, H
    LEDERIS, K
    CASSAR, L
    BISBY, MA
    JOURNAL OF NEUROSCIENCE, 1989, 9 (04): : 1303 - 1313
  • [33] REMODELING OF B-50 (GAP-43)-IMMUNOREACTIVE AND NSE-IMMUNOREACTIVE MUCOSAL NERVES IN THE INTESTINES OF RATS INFECTED WITH NIPPOSTRONGYLUS-BRASILIENSIS
    STEAD, RH
    KOSECKAJANISZEWSKA, U
    OESTREICHER, AB
    DIXON, MF
    BIENENSTOCK, J
    JOURNAL OF NEUROSCIENCE, 1991, 11 (12): : 3809 - 3821
  • [34] Endogenous ADP-ribosylation of phosphoprotein B-50/GAP-43 and other neuronal substrates
    Zwiers, H
    Hollenberg, MD
    McLean, KN
    Philibert, KD
    ADP-RIBOSYLATION IN ANIMAL TISSUES: STRUCTURE, FUNCTION, AND BIOLOGY OF MONO (ADP-RIBOSYL) TRANSFERASES AND RELATED ENZYMES, 1997, 419 : 279 - 288
  • [35] THE NEUROPIL AND GAP-43/B-50 IN NORMALLY AGING AND ALZHEIMERS-DISEASE HUMAN BRAIN
    COLEMAN, PD
    ROGERS, KE
    FLOOD, DG
    PROGRESS IN BRAIN RESEARCH, 1991, 89 : 263 - 269
  • [36] Distribution of B-50[GAP-43) mRNA and protein in the normal adult human spinal cord
    Brook, GA
    Schmitt, AB
    Nacimiento, W
    Weis, J
    Schröder, JM
    Noth, J
    ACTA NEUROPATHOLOGICA, 1998, 95 (04) : 378 - 386
  • [37] Distribution of B-50(GAP-43) mRNA and protein in the normal adult human spinal cord
    G. A. Brook
    A. B. Schmitt
    W. Nacimiento
    J. Weis
    J. M. Schröder
    J. Noth
    Acta Neuropathologica, 1998, 95 : 378 - 386
  • [38] PRESYNAPTIC PKC SUBSTRATE B-50 (GAP-43) AND NEUROTRANSMITTER RELEASE - STUDIES WITH PERMEATED SYNAPTOSOMES
    DEGRAAN, PNE
    HENS, JJH
    GISPEN, WH
    NEUROTOXICOLOGY, 1994, 15 (01) : 41 - 47
  • [39] 3,4-DIAMINOPYRIDINE EVOKED NOREPINEPHRINE RELEASE AND B-50 (GAP-43) PHOSPHORYLATION
    HUANG, HY
    TANG, T
    CHEN, XF
    ACTA PHARMACOLOGICA SINICA, 1993, 14 (01): : 35 - 38
  • [40] Overexpression of B-50/GAP-43 induces formation of filopodia in PC12 cells
    Aarts, LHJ
    Nielander, HB
    Oestreicher, AB
    Schrama, LH
    Gispen, WH
    Schotman, P
    NEUROCHEMISTRY: CELLULAR, MOLECULAR, AND CLINICAL ASPECTS, 1997, : 1107 - 1110